Immune-Onc Therapeutics Inc

Call
Website
1059 E Meadow Cir
Palo Alto, CA 94303
+1 (650) 460-7691
https://www.immune-onc.com

Immune-Onc Therapeutics Inc., based in Palo Alto, CA, is a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting myeloid cells to advance treatment options for blood cancers, solid tumors, and autoimmune diseases. The company aims to revolutionize immunology and oncology drug development by validating myeloid cell surface proteins as critical therapeutic targets.

With a commitment to translating scientific discoveries into effective treatments, Immune-Onc is building a portfolio of novel antibodies designed to modulate or deplete specific subsets of myeloid cells. Their team, comprised of industry experts and strategic collaborators, is dedicated to expanding the benefits of immunotherapy for a broader range of patients suffering from serious diseases.

Generated from the website

Also at this address

Owner verified
See a problem?

You might also like

Blood derivatives

EB Pharma, LLC

EB Pharma, LLC is a pharmaceutical company based in Palo Alto, CA, specializing in the development of innovative medical solutions. With a focus on research and product development, EB Pharma, LLC aims to address unmet medical needs and improve patient outcomes through cutting-edge technology and scientific advancements. Generated from their business information
Blood derivatives, Drugs and drug proprietaries

Eiger BioPharmaceuticals, Inc

Eiger Biopharmaceuticals is a research-driven biopharmaceutical company based in Palo Alto, CA. The company focuses on developing innovative therapies for serious diseases with unmet medical needs. Utilizing cutting-edge technology and scientific expertise, Eiger Biopharmaceuticals is dedicated to advancing novel treatments to improve patient outcomes and quality of life. Generated from their business information
Song writings, Blood derivatives

Kodiak Sciences Inc

Kodiak Sciences Inc. is a biopharmaceutical company based in Palo Alto, California, dedicated to researching, developing, and commercializing innovative therapies for high-prevalence retinal diseases. The company focuses on addressing significant conditions such as age-related macular degeneration and diabetic retinopathy, aiming to improve the quality of life for millions affected by these conditions. Utilizing its proprietary ABC platform, Kodiak is advancing a pipeline of novel treatments, including bispecific antibody biopolymer conjugates. The company's commitment to scientific excellence is reflected in its ongoing clinical trials and recent positive results, reinforcing its mission to transform the landscape of ocular disease treatment. Generated from the website
United States›California›Palo Alto›Immune-Onc Therapeutics Inc

Partial Data by Infogroup (c) 2025. All rights reserved.